Home › Alopecia Areata › Florida › Miami
Alopecia Areata clinical trials in Miami, FL
6 studies for Alopecia Areata are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
RecruitingPhase 3
- Pediatric Skin Research, Miami
- Skin Research of South Florida, Miami
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
RecruitingPhase 3
- Pediatric Skin Research - Miami /ID# 283281, Miami
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
RecruitingPhase 3
- Skin Research of South Florida, Miami
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
RecruitingPhase 3
- Lenus Research and Medical Group /ID# 259356, Miami
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
RecruitingPhase 3
- Pediatric Skin Research, Miami
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
RecruitingPhase 3
- All X Ray Diagnostic Services Corp, Miami
- Millennium Medical Research Llc, Miami
- Florida International Medical Research, Miami
- and 5 more
Alopecia Areata trials in other cities
- Indianapolis, IN7 studies
- San Antonio, TX6 studies
- Omaha, NE5 studies
- New York City, NY4 studies
- Los Angeles, CA3 studies
- Spokane, WA3 studies
- Portland, OR3 studies
- Houston, TX3 studies
- Columbus, OH3 studies
- Troy, MI3 studies
- Irvine, CA3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.